Cue Health awarded $30m base funding from US Department of Health and Human Services’ BARDA
Healthcare technology Cue Health (Cue) has secured $30m in base funding and option from the US Department of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jul 18
Healthcare technology Cue Health (Cue) has secured $30m in base funding and option from the US Department of…
13 Jul 18
Abbott has secured approval from the US Food and Drug Administration (FDA) for its next-generation MitraClip device to…
13 Jul 18
Vivior, a Swiss digital health start-up, has recently closed an investment round with private investors from Europe and…
13 Jul 18
Health technology firm Royal Philips has signed two long-term strategic partnership agreements with hospital groups in Germany.
13 Jul 18
NOW Diagnostics has acquired CELLMIC’s rapid assay reader product lines and related assets for an undisclosed price in…
13 Jul 18
Gerresheimer has agreed to acquire Swiss medical technology company, Sensile Medical, in a deal valued at around €350m.
13 Jul 18
EchoNous has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its ultrasound-based tool developed…
13 Jul 18
Bittium has invested in Swiss medical remote diagnostics service provider, evismo, in a bid to expand its medical…
12 Jul 18
Angiodroid Srl has secured CE mark for ANGIOPULSE, its first intra-aortic balloon pump (IABP) device.
12 Jul 18
Hologic's Cynosure division has launched TempSure Vitalia, an FDA-cleared and Health Canada-approved advanced radiofrequency treatment, in North America.